Saved in:
| Main Author: | Seeba Zachariah |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Centro de investigaciones y Publicaciones Farmacéuticas
2020
|
| Subjects: | |
| Online Access: | https://www.redalyc.org/articulo.oa?id=69063423014 https://www.redalyc.org/journal/690/69063423014/ https://www.redalyc.org/journal/690/69063423014/html/ https://www.redalyc.org/journal/690/69063423014/69063423014.epub https://www.redalyc.org/journal/690/69063423014/movil |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Pharmacist recommendations for prophylactic enoxaparin monitoring and dose adjustment in trauma patients admitted to a surgical intensive care unit
by: Ali Scrimenti
Published: (2019)
by: Ali Scrimenti
Published: (2019)
New anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries. A systematic review of randomized controlled trials
by: Ricardo de Alvarenga Yoshida
Published: (2012)
by: Ricardo de Alvarenga Yoshida
Published: (2012)
Randomized, controlled, multi‐center phase II study of postoperative enoxaparin treatment for venous thromboembolism prophylaxis in patients undergoing surgery for hepatobiliary‐pancreatic malignancies
by: Go Shinke, et al.
Published: (2024)
by: Go Shinke, et al.
Published: (2024)
Clinical significance of recurrent venous thromboembolism
by: Nicos Labropoulos
Published: (2010)
by: Nicos Labropoulos
Published: (2010)
Intravenous enoxaparin guided by anti‐Xa in venovenous extracorporeal membrane oxygenation: A retrospective, single‐center study
by: Miroslav Durila, et al.
Published: (2024)
by: Miroslav Durila, et al.
Published: (2024)
Assessment of non-cardiac surgical patients using the ACS-NSQIP calculator to predict the risk of pneumonia, cardiac complications and venous thromboembolism
by: INDHIRA PACHANO-GARCÍA
Published: (2021)
by: INDHIRA PACHANO-GARCÍA
Published: (2021)
Estimated impact of model‐guided venous thromboembolism prophylaxis versus real‐world practice
by: Benjamin G Mittman, et al.
Published: (2026)
by: Benjamin G Mittman, et al.
Published: (2026)
Hospital‐associated venous thromboembolism prophylaxis use by risk assessment at a large integrated health care network in Northern California
by: James Xu, et al.
Published: (2024)
by: James Xu, et al.
Published: (2024)
Individualización posológica de enoxaparina en un obeso extremo mediante la monitorización del factor anti-Xa
by: Arantxa Andujar Mateos
Published: (2016)
by: Arantxa Andujar Mateos
Published: (2016)
Safety and efficacy of anti‐coagulation for primary and secondary venous thromboembolism prophylaxis in hospitalized adolescents and young adults with sickle cell disease: An institutional experience
by: Vilmarie Rodriguez, et al.
Published: (2026)
by: Vilmarie Rodriguez, et al.
Published: (2026)
Risk factors for deep venous thrombosis in patients undergoing orthopedic surgical procedures
by: Marco Antonio González Fuenmayor
Published: (2022)
by: Marco Antonio González Fuenmayor
Published: (2022)
A descriptive study of antithrombotic medication patterns in adult patients with recent venous thromboembolism
by: Fady Allahwerdy
Published: (2019)
by: Fady Allahwerdy
Published: (2019)
Multicenter study evaluating target attainment of anti‐Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients
by: Tyler Chanas, et al.
Published: (2024)
by: Tyler Chanas, et al.
Published: (2024)
Clonal haemopoiesis and venous thromboembolism risk
by: David P. Steensma
Published: (2024)
by: David P. Steensma
Published: (2024)
Peculiaridades da terapia trombolítica na síndrome nefrótica pediátrica: monitorização do fator anti-Xa
by: Patrícia Zambi Meirelles
Published: (2008)
by: Patrícia Zambi Meirelles
Published: (2008)
Venous thromboembolism prevention protocol for adapting prophylaxis recommendations to the potential risk post total knee replacement: a randomized controlled trial
by: Mariam A. Alameri
Published: (2020)
by: Mariam A. Alameri
Published: (2020)
DOAC‐Remove to counteract the interference of anti‐Xa oral anticoagulants on the monitoring of heparin
by: Sophie Melicine, et al.
Published: (2024)
by: Sophie Melicine, et al.
Published: (2024)
New horizons in the pharmacological management of venous thromboembolism
by: Andreas Verstraete, et al.
Published: (2025)
by: Andreas Verstraete, et al.
Published: (2025)
Cost-effectiveness analysis of apixaban compared to low-molecular-weight heparins and vitamin k antagonists for treatment and secondary prevention of venous thromboembolism
by: Isabel Elías
Published: (2016)
by: Isabel Elías
Published: (2016)
Pulmonary thromboembolism in an anticoagulated oncological patient
by: Diana Alegre-González
Published: (2023)
by: Diana Alegre-González
Published: (2023)
Navigating venous thromboembolism risks in lung cancer patients
by: Si‐Wai Vivian Chiu, et al.
Published: (2024)
by: Si‐Wai Vivian Chiu, et al.
Published: (2024)
Synchronous eyelid oncocytoma and conjunctival intraepithelial neoplasia
by: Zachariah Chowdhury
Published: (2021)
by: Zachariah Chowdhury
Published: (2021)
Fatal pulmonary thromboembolism associated with uterine carcinosarcoma
by: Giorgia Lodetti
Published: (2023)
by: Giorgia Lodetti
Published: (2023)
De novo chronic lymphocytic leukemia/prolymphocytic leukemia or B-cell prolymphocytic leukemia? The importance of integrating clinico-morphological and immunophenotypic findings in distinguishing chronic lymphoproliferative diseases with circulating phase
by: Zachariah Chowdhury
Published: (2021)
by: Zachariah Chowdhury
Published: (2021)
Nodal Langerhans cell neoplasm: detailing the diagnostic quandaries
by: Zachariah Chowdhury
Published: (2021)
by: Zachariah Chowdhury
Published: (2021)
Periprostatic venous thrombosis
by: Eduardo Paulino
Published: (2016)
by: Eduardo Paulino
Published: (2016)
Differential risks of venous thromboembolic events in pemphigus and pemphigoid diseases
by: Maren E. Buenning, et al.
Published: (2025)
by: Maren E. Buenning, et al.
Published: (2025)
Clinical guideline highlights for the hospitalist: Management of pediatric venous thromboembolism
by: Carly Noel, et al.
Published: (2026)
by: Carly Noel, et al.
Published: (2026)
Efficacy and safety of bemiparin as treatment of venous thromboembolic disease in the elderly
by: Javier Ena, et al.
Published: (2024)
by: Javier Ena, et al.
Published: (2024)
Attention to the risk of venous thromboembolism in mechanically restrained hospitalised patients
by: Adrian Chee, et al.
Published: (2024)
by: Adrian Chee, et al.
Published: (2024)
Interpreting the risk of venous thromboembolism with JAK inhibitors in atopic dermatitis
by: Sheng Li, et al.
Published: (2025)
by: Sheng Li, et al.
Published: (2025)
Vancomycin use, dosing and serum trough concentrations in the pediatric population: a retrospective institutional review
by: Kevin Rajon
Published: (2017)
by: Kevin Rajon
Published: (2017)
Association between venous thromboembolism‐associated genetic variants, coagulation factor levels, and thrombin generation potential
by: Jihee Han, et al.
Published: (2024)
by: Jihee Han, et al.
Published: (2024)
Napoleon Bonaparte: An Emperor who died needing good surgical care
by: Kaushik Bhattacharya
Published: (2022)
by: Kaushik Bhattacharya
Published: (2022)
Potency evaluation of unfractionated heparins commercialized in Brazil through anti-factor Xa and anti-factor IIa chromogenic tests and coagulation assay
by: Renata Jurema Medeiros
Published: (2023)
by: Renata Jurema Medeiros
Published: (2023)
Associations of blood pressure in the third trimester and risk of venous thromboembolism postpartum
by: Qian Li, et al.
Published: (2024)
by: Qian Li, et al.
Published: (2024)
Comparison of the effect of compression stockings with heparin and enoxaparin in the prevention of deep vein thrombosis in lower limbs of hysterectomy patients
by: M.D Enhesari A
Published: (2019)
by: M.D Enhesari A
Published: (2019)
Prevalence of risk factors for venous thromboembolism and aspirin resistance in Australian patients undergoing total hip and knee arthroplasty
by: Nameer van Oosterom, et al.
Published: (2024)
by: Nameer van Oosterom, et al.
Published: (2024)
The efficacy of aspirin versus low‐molecular‐weight heparin for venous thromboembolism prophylaxis after knee and hip arthroplasty: A systematic review and meta‐analysis of randomized controlled trials
by: Loay A. Salman, et al.
Published: (2024)
by: Loay A. Salman, et al.
Published: (2024)
Nursing care in surgical inpatient unit: perception of patients
by: Diéssica Roggia Piexak
Published: (2016)
by: Diéssica Roggia Piexak
Published: (2016)
Similar Items
-
Pharmacist recommendations for prophylactic enoxaparin monitoring and dose adjustment in trauma patients admitted to a surgical intensive care unit
by: Ali Scrimenti
Published: (2019) -
New anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries. A systematic review of randomized controlled trials
by: Ricardo de Alvarenga Yoshida
Published: (2012) -
Randomized, controlled, multi‐center phase II study of postoperative enoxaparin treatment for venous thromboembolism prophylaxis in patients undergoing surgery for hepatobiliary‐pancreatic malignancies
by: Go Shinke, et al.
Published: (2024) -
Clinical significance of recurrent venous thromboembolism
by: Nicos Labropoulos
Published: (2010) -
Intravenous enoxaparin guided by anti‐Xa in venovenous extracorporeal membrane oxygenation: A retrospective, single‐center study
by: Miroslav Durila, et al.
Published: (2024)